These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30735094)
1. Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches. Pourtaghi-Anvarian S; Mohammadi S; Hamzeh-Mivehroud M; Alizadeh AA; Dastmalchi S Prep Biochem Biotechnol; 2019; 49(1):38-47. PubMed ID: 30735094 [TBL] [Abstract][Full Text] [Related]
2. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology. Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628 [TBL] [Abstract][Full Text] [Related]
3. Downstream characterization of anti-TNF-α single chain variable fragment antibodies. Abdolalizadeh J; Nouri M; Zolbanin JM; Baradaran B; Barzegari A; Omidi Y Hum Antibodies; 2012; 21(1-2):41-8. PubMed ID: 22885959 [TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology. Alizadeh AA; Hamzeh-Mivehroud M; Dastmalchi S Adv Pharm Bull; 2015 Dec; 5(Suppl 1):661-6. PubMed ID: 26793613 [TBL] [Abstract][Full Text] [Related]
5. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy. Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313 [TBL] [Abstract][Full Text] [Related]
6. A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides. Geng S; Chang H; Qin W; Lv M; Li Y; Feng J; Shen B Immunol Res; 2015 Jul; 62(3):377-85. PubMed ID: 26059602 [TBL] [Abstract][Full Text] [Related]
7. Optimization and modification of anti-rhTNF-α single chain variable fragment antibody: effective in vitro affinity maturation and functional expression of chimeric Fab. Miao X; Li A; Chen W; Qi H; Qiu Z; Zhang Y; Zhang J; Wang M Biomed Pharmacother; 2013 Jun; 67(5):437-44. PubMed ID: 23582792 [TBL] [Abstract][Full Text] [Related]
8. A novel human scFv fragment against TNF-alpha from de novo design method. Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112 [TBL] [Abstract][Full Text] [Related]
9. A strategy for high-level expression of a single-chain variable fragment against TNFα by subcloning antibody variable regions from the phage display vector pCANTAB 5E into pBV220. Yang T; Yang L; Chai W; Li R; Xie J; Niu B Protein Expr Purif; 2011 Mar; 76(1):109-14. PubMed ID: 20951213 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Novel Fragment Antibodies Against TNF-alpha Isolated Using Phage Display Technique. Alizadeha AA; Hamzeh-Mivehroud M; Haddad E; Haddad N; Sharifi M; Mohammadi S; Pourtaghi-Anvarian S; Dastmalchi S Iran J Pharm Res; 2019; 18(2):759-771. PubMed ID: 31531059 [TBL] [Abstract][Full Text] [Related]
11. A novel bivalent single-chain variable fragment (scFV) inhibits the action of tumour necrosis factor alpha. Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H Biotechnol Appl Biochem; 2008 Aug; 50(Pt 4):173-9. PubMed ID: 18047471 [TBL] [Abstract][Full Text] [Related]
12. Isolation and Characterization of Novel Phage Displayed scFv Fragment for Human Tumor Necrosis Factor Alpha and Molecular Docking Analysis of Their Interactions. Safarpour H; Shahmirzaie M; Rezaee E; Barati M; Safarnejad MR; H Shirazi F Iran J Pharm Res; 2018; 17(2):743-752. PubMed ID: 29881431 [TBL] [Abstract][Full Text] [Related]
13. Overexpression, effective renaturation, and bioactivity of novel single-chain antibodies against TNF-alpha. Geng S; Chang H; Qin W; Li Y; Feng J; Shen B Prep Biochem Biotechnol; 2008; 38(1):74-86. PubMed ID: 18080912 [TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of single-chain variable fragment antibody against staphylococcal enterotoxin A in Escherichia coli. Chen W; Hu L; Liu A; Li J; Chen F; Wang X Can J Microbiol; 2014 Nov; 60(11):737-43. PubMed ID: 25322256 [TBL] [Abstract][Full Text] [Related]
15. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action. Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a TNF alpha antagonist derived from a monoclonal antibody. Döring E; Stigler R; Grütz G; von Baehr R; Schneider-Mergener J Mol Immunol; 1994 Oct; 31(14):1059-67. PubMed ID: 7935497 [TBL] [Abstract][Full Text] [Related]
17. Development of recombinant single-chain variable fragment against hepatitis A virus and its use in quantification of hepatitis A antigen. Nimmagadda SV; Aavula SM; Biradhar N; Sula S; Lingala R; Chandran D; Villuppanoor SA Biologicals; 2012 Jul; 40(4):299-308. PubMed ID: 22613789 [TBL] [Abstract][Full Text] [Related]
18. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries. Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781 [TBL] [Abstract][Full Text] [Related]
19. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related]
20. An affinity improved single-chain antibody from phage display of a library derived from monoclonal antibodies detects fumonisins by immunoassay. Hu ZQ; Li HP; Wu P; Li YB; Zhou ZQ; Zhang JB; Liu JL; Liao YC Anal Chim Acta; 2015 Mar; 867():74-82. PubMed ID: 25813030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]